Xinhua news agency reported disclosed by foreign media that Analysis results during the Phase III clinical trial of the COVID-19 vaccine. The Chinese company CanSino is effective against COVID-19. That showed symptoms at 65.7% and effective prevention of COVID-19. Up to 90.98% of severe symptoms with a single injection.
On Monday, Reuters reported,
เกมยิงปลา citing data from Pakistani health officials that Efficacy Analysis of the COVID-19 Vaccine The type 5 adinovirus carrier type (Ad5-nCoV) was obtained from 30,000 test participants in many countries. And COVID-19 patients 101 confirmed cases by an independent data review committee in Pakistan conducted such analyzes.
Faisal Sultan, Special Assistant to Public Health of the Prime Minister of Pakistan Tweet the message: "If only counted in Pakistan The efficacy of the vaccine against COVID-19 The symptoms were 74.8% and effective in preventing COVID-19. With severe symptoms at 100% "and added that There were no reports of serious safety concerns.
Last November Cancino said. Phase III clinical trials are being conducted in Russia, Pakistan and Mexico, while approval of Phase III clinical trials in several other countries is being sought.
The vaccine was co-developed by Cancino and the Chinese Academy of Military Sciences (AMS).